Product NDC: | 0703-5748 |
Proprietary Name: | Cisplatin |
Non Proprietary Name: | Cisplatin |
Active Ingredient(s): | 100 mg/100mL & nbsp; Cisplatin |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0703-5748 |
Labeler Name: | Teva Parenteral Medicines, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074656 |
Marketing Category: | ANDA |
Start Marketing Date: | 20000601 |
Package NDC: | 0703-5748-11 |
Package Description: | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-5748-11) > 100 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 0703-5748-11 |
Proprietary Name | Cisplatin |
Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-5748-11) > 100 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 0703-5748 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cisplatin |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20000601 |
Marketing Category Name | ANDA |
Labeler Name | Teva Parenteral Medicines, Inc. |
Substance Name | CISPLATIN |
Strength Number | 100 |
Strength Unit | mg/100mL |
Pharmaceutical Classes | Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] |